Entrada Therapeutics Cash Flow Statement (2020-2026) | TRDA

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-9.90M-14.43M-18.45M-21.67M-23.18M-25.14M-24.63M-6.67M-25.93M35.46M-9.46M23.50M54.99M-13.99M1.06M-17.35M-43.12M-44.18M-39.20M-39.72M
Depreciation and Depletion (Quarter)
0.30M0.30M0.32M0.39M0.50M0.50M0.53M0.54M0.70M0.80M0.69M0.90M0.90M0.90M0.97M0.90M1.10M1.20M0.89M0.80M
Share-based Compensation (Quarter)
0.33M0.58M1.46M1.79M2.51M2.71M2.88M2.75M3.12M3.40M3.84M3.73M4.62M4.86M4.70M5.09M5.05M5.12M4.36M4.74M
Gains from Sales and Divestitures (Quarter)
0.01M0.01M
Gains from Investment Securities (Quarter)
0.02M-2.00M0.56M-0.56M8.63M0.68M68.27M-0.03M-2.02M-0.00M6.67M-0.04M-0.04M-0.04M-0.09M0.02M
Non-cash Items (Quarter)
0.14M26.73M
Cash from Operations (Quarter)
-7.91M-14.07M-20.54M-20.99M-18.01M-27.48M-27.30M203.40M-35.09M-24.49M-4.01M-25.52M39.83M-24.27M-31.61M-38.51M-29.49M-28.31M-32.20M-41.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.14M-0.14M0.03M0.10M0.24M1.69M1.85M2.00M2.04M2.26M3.21M2.51M1.34M0.96M0.74M0.63M0.55M
Depreciation & Amortization (CF) (Quarter)
0.30M0.30M0.32M0.39M0.50M0.50M0.53M0.54M0.70M0.80M0.69M0.90M0.90M0.90M0.97M0.90M1.10M1.20M0.89M0.80M
Change in Working Capital
Change in Account Payables (Quarter)
0.50M0.08M-1.03M2.06M1.54M-2.91M4.59M0.53M-4.38M-1.36M2.41M-0.66M-0.89M-0.31M2.85M-1.91M-0.32M1.31M-0.88M0.64M
Change in Accured Expenses (Quarter)
0.58M2.06M1.82M-1.53M0.73M6.90M-4.34M4.11M-5.05M2.80M1.96M-2.52M1.62M3.04M-0.42M-5.46M4.31M3.74M2.15M-5.95M
Change in Taxes (Quarter)
7.36M-7.36M4.02M1.83M-1.74M-1.86M-1.58M0.14M-0.80M0.62M-0.62M
Investing Activities
Capital Expenditures (Quarter)
1.54M0.81M1.32M0.39M0.28M1.51M-2.09M1.67M1.52M-2.89M-0.09M0.84M1.05M-1.82M0.50M1.14M-1.14M1.04M
Change in Acquisitions & Divestments (Quarter)
1.71M25.00M30.00M19.50M63.00M28.39M74.50M108.54M123.92M87.36M83.31M118.50M85.95M50.63M75.50M47.38M38.86M
Cash from Investing Activities (Quarter)
-1.54M-0.81M-1.32M-181.53M24.23M-10.13M18.79M-40.44M-113.26M-3.74M19.04M26.15M-24.38M-82.93M53.37M4.78M33.80M49.11M29.12M26.99M
Financing Activities
Change in Capital Stock
Shares Issued (Quarter)
0.21M0.11M190.34M0.28M0.13M0.26M0.37M-0.31M0.21M99.79M-98.31M1.09M0.35M-0.35M0.32M0.11M0.10M
Preferred Shares Issued (Quarter)
-0.42M
Misc.
Cash from Financing Activities (Quarter)
0.21M0.11M190.75M0.05M0.01M0.06M0.36M19.54M0.44M0.37M0.69M0.21M101.37M-0.01M1.40M0.35M0.34M0.01M0.19M0.10M
Change in Cash (Quarter)
-9.24M-14.78M168.89M-202.47M6.23M-37.56M-8.15M182.49M-147.91M-27.86M15.72M0.83M116.82M-107.20M23.16M-33.37M4.64M20.80M-2.89M-14.61M
Free Cash Flow (Quarter)
-9.45M-14.88M-21.86M-21.38M-18.29M-28.99M-25.21M201.73M-36.61M-21.60M-3.92M-26.36M38.79M-22.44M-32.10M-39.65M-28.34M-28.31M-33.24M-41.70M
Net Cash Flow (Quarter)
-9.24M-14.78M168.89M-202.47M6.23M-37.56M-8.15M182.49M-147.91M-27.86M15.72M0.83M116.82M-107.20M23.16M-33.37M4.64M20.80M-2.89M-14.61M